Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy

PURPOSE: Ongoing angiogenesis renders the tumor endothelium unresponsive to inflammatory cytokines and interferes with adhesion of leukocytes, resulting in escape from immunity. This process is referred to as tumor endothelial cell anergy. We aimed to investigate whether anti-angiogenic agents can o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak-Sliwinska, Patrycja, van Beijnum, Judy R., Griffioen, Christian J., Huinen, Zowi R., Sopesens, Nadine Grima, Schulz, Ralph, Jenkins, Samir V., Dings, Ruud P. M., Groenendijk, Floris H., Huijbers, Elisabeth J. M., Thijssen, Victor L. J. L., Jonasch, Eric, Vyth-Dreese, Florry A., Jordanova, Ekaterina S., Bex, Axel, Bernards, René, de Gruijl, Tanja D., Griffioen, Arjan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119234/
https://www.ncbi.nlm.nih.gov/pubmed/36459240
http://dx.doi.org/10.1007/s10456-022-09863-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119234/
https://www.ncbi.nlm.nih.gov/pubmed/36459240
http://dx.doi.org/10.1007/s10456-022-09863-4

Ejemplares similares